$232 Million is the total value of INTERWEST VENTURE MANAGEMENT CO's 12 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 33.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| REAL | THE REALREAL | $126,372,000 | -15.7% | 6,704,080 | 0.0% | 54.48% | -5.3% | |
| GKOS | Buy | GLAUKOS CORP | $55,198,000 | +7685.3% | 1,013,364 | +8827.5% | 23.80% | +8648.5% |
| MGNX | MACROGENICS INC | $11,689,000 | -14.7% | 1,074,316 | 0.0% | 5.04% | -4.2% | |
| EIGR | EIGER BIOPHARMACEUTICALS INC | $11,397,000 | +45.4% | 764,918 | 0.0% | 4.91% | +63.3% | |
| KALV | KALVISTA PHARMACEUTICALS INC | $6,924,000 | +53.5% | 388,766 | 0.0% | 2.98% | +72.4% | |
| AGTC | APPLIED GENETIC TECHNOL CORP | $6,581,000 | +8.7% | 1,455,904 | 0.0% | 2.84% | +22.1% | |
| CDTX | CIDARA THERAPEUTICS INC | $5,210,000 | +92.5% | 1,356,813 | 0.0% | 2.25% | +116.2% | |
| STIM | NEURONETICS INC | $4,628,000 | -46.0% | 1,030,689 | 0.0% | 2.00% | -39.3% | |
| VERO | New | VENUS CONCEPT INC | $3,096,000 | – | 658,657 | +100.0% | 1.34% | – |
| OBALON THERAPEUTICS INC | $722,000 | -2.2% | 380,224 | 0.0% | 0.31% | +9.9% | ||
| XENE | XENON PHARMACEUTICALS INC | $109,000 | +45.3% | 8,293 | 0.0% | 0.05% | +62.1% | |
| DARE | New | DARE BIOSCIENCE INC | $41,000 | – | 50,368 | +100.0% | 0.02% | – |
| HAIR | Exit | RESTORATION ROBOTICS INC | $0 | – | -5,355,786 | -100.0% | -1.34% | – |
| AVDR | Exit | AVEDRO | $0 | – | -2,745,244 | -100.0% | -23.91% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-01-23
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GLAUKOS CORP | 28 | Q3 2023 | 33.0% |
| EIGER BIOPHARMACEUTICALS INC | 24 | Q3 2022 | 17.7% |
| APPLIED GENETIC TECHNOL CORP | 24 | Q3 2022 | 6.7% |
| XENON PHARMACEUTICALS INC | 20 | Q3 2021 | 0.6% |
| CIDARA THERAPEUTICS INC | 19 | Q2 2021 | 4.5% |
| THE REALREAL | 18 | Q3 2023 | 62.6% |
| KALVISTA PHARMACEUTICALS INC | 17 | Q4 2020 | 10.8% |
| DARE BIOSCIENCE INC | 16 | Q3 2023 | 0.3% |
| MACROGENICS INC | 14 | Q1 2020 | 19.2% |
| PMV PHARMACEUTICALS INC | 13 | Q3 2023 | 67.5% |
View INTERWEST VENTURE MANAGEMENT CO's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 144 | 2024-02-27 |
| 13F-HR | 2023-10-20 |
| 13F-HR | 2023-07-21 |
| 13F-HR | 2023-04-27 |
| 13F-HR | 2023-01-31 |
| 13F-HR | 2022-10-25 |
| 13F-HR | 2022-08-02 |
| 13F-HR | 2022-04-13 |
| 13F-HR | 2022-01-25 |
| 13F-HR | 2021-10-19 |
View INTERWEST VENTURE MANAGEMENT CO's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.